Search Browse Earnings

Peak Bio, Inc. — SlamSEC

Peak Bio, Inc.

Biological Products, (No Diagnostic Substances)·PLEASANTON, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$607,681

+15.0% YoY

FY 2023

Adj. EBITDA

-$11.7M

-1924.7% margin

FY 2023

Net Income

-$13.1M

-2153.9% margin

FY 2023

EPS (Diluted)

-$0.74

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$654,892

FY 2023

Total Debt

$7.7M

FY 2022

Net Debt

$7.0M

FY 2022

Enterprise Value

—

Debt / EBITDA

-0.6x

FY 2023

EV / EBITDA

—

Employees

—